Wednesday 22 July 2015

Should the human papillomavirus (hpv) vaccine be mandatory for early adolescent girls

Top sites by search query "should the human papillomavirus (hpv) vaccine be mandatory for early adolescent girls"

  http://www.x-rx.net/blog/
Even this year, everybody should get it, because gosh, so much money was spent making all those millions of shots and who knows, they might help a little. It has been shown to decrease the incidence of precancerous lesions in limited studies provided by the manufacturer, many of which would have resolved spontaneously or with treatment

  http://scienceblogs.com/insolence/2011/09/06/oh-no-theres-dna-in-my-gardasil/
Does this matter? One factor to consider is how much DNA was present, which was almost certainly very, very little, given that it took nested PCR to detect it. Lee worries about, the minute amount of rDNA in the HPV vaccine would have to: Find its way into human cells in significant quantities, which is highly unlikely given the tiny amount that, even in the worst case, is there

  http://www.angelfire.com/az/sthurston/cervical_cancer_vaccine.html
Negative side effects of GARDASIL, a new Merck vaccine to prevent the sexually transmitted virus that causes cervical cancer, are being reported in the District of Columbia and 20 states, including Virginia. "A report to the Vaccine Adverse Event Reporting System does not necessarily mean the adverse event was serious or that it was caused by the vaccine," said CDC spokesman Curtis Allen

Family Research Council


  http://www.frc.org/get.cfm?i=IF07B01
Q: Would FRC support a policy whereby schools promote the vaccine on an "opt-in" basis?A: Yes, in contrast to opt-out policy, opt-in policies allow parents to make the decision concerning their child's level of risk and whether or not to vaccinate. Q: Is an opt-out policy enough to protect parental rights? A: No, an opt-out policy would likely mislead parents to believe immunization with Gardasil is necessary to protect their child's health while in the school setting

HPV Vaccination in India: Critical Appraisal


  http://www.hindawi.com/journals/isrn/2014/394595/
It is also expected to reduce the need for common excisional treatments for cervical dysplasia in vaccinated women which is an important outcome of vaccination. This low coverage was surprising in the presence of enormous funding, good awareness among parents and health care workers, and various national health programmes

  http://www.kkrasnowwaterman.com/blog/tabid/2962/bid/1691/HPV-Vaccine-fainting-seizures-and-other-side-effects.aspx
When you asked me where I learned that MOST girls tolerated the shot, it was a report done from VAERS that stated 94 percent of girls had no or non-serious side effects. Now that her eye has gotten better, she has another infection in her right nostril, which has resulted in significant swelling on the right side of her nose and entire face

  http://www.rho.org/about-cervical-cancer.htm
Duration of effectiveness Clinical trials show that HPV vaccines are effective for at least five to six years (the duration to date, based on follow-up data from the major trials), but they are likely to be effective for much longer.30,31 Preliminary results from a trial of the HPV 16 component of the quadrivalent vaccine indicate that it is effective for up to 8.5 years.32 During the long-term follow-up, there has been no evidence of decreased efficacy for prevention of infection or lesions. Many do not know the cause and burden of cervical cancer and may not be able to understand the value of HPV vaccines or cervical screening for improving the current situation

  http://www.health.gov.on.ca/en/ms/hpv/expert_qa.aspx
Answered by: Nina Arron - RN, MHA Q: What are the risks of getting the HPV vaccine? A: Like with most other vaccines, there may be mild side effects in some people. Answered by: Nina Arron - RN, MHA Q: When will the vaccination program start? A: The HPV vaccine will be offered to all female students in Grade 8 beginning in the fall

  http://www.sciencedirect.com/science/article/pii/S0264410X12007578
Safety evaluations are important and communication about vaccine safety is critical, as events temporally associated with vaccination can be falsely attributed to vaccination. Different health care systems and infrastructure have resulted in varied implementation strategies, with some countries delivering vaccine in schools and others through health centers or primary care providers

The Human Papillomavirus (HPV) Vaccine


  http://www.health.ny.gov/diseases/communicable/human_papillomavirus/
It can also cause cancers of the cervix, vagina, and vulva in women, cancer of the penis in men, and cancers of the anus and the mouth or throat, in both women and men. The HPV vaccine is also recommended by the Centers for Disease Control and Prevention (CDC), the American Academy of Pediatrics (AAP), American Academy of Family Physicians, and the Society for Adolescent Health and Medicine

  http://www.sciencedirect.com/science/article/pii/S0264410X13012723
However, HPV vaccines are presently not recommended for preventing oropharyngeal cancer, although they have been shown to be highly effective against the HPV strains that are most commonly found in the oropharynx

  http://www.biomedcentral.com/1472-698X/15/4
However, there was an increase in the intention to obtain injections to protect against both STDs and cancer among the girls, illustrating that preadolescent girls were motivated by the education strategy to prevent both STDs and cancer (i.e., cervical cancer). Abstract Background This study aimed to determine the awareness among fifth-grade girls and boys of sexually transmitted diseases (STDs), cancer, and human papillomavirus (HPV), and to determine the factors associated with intention to obtain the HPV vaccination

  http://archinte.jamanetwork.com/article.aspx?articleid=2109856
By using it you agree that that you are requesting the material solely for personal, non-commercial use, and that it is subject to the AMA's Terms of Use. Return to: Incidence of Sexually Transmitted Infections After Human Papillomavirus Vaccination Among Adolescent Females This feature is provided as a courtesy

  http://www.who.int/bulletin/volumes/85/9/06-038414/en/
Results of dynamic simulation models of HPV transmission suggest that if high coverage of females can be achieved, there is little additional reduction in cervical cancer to be gained by vaccinating males.42,43 At lower coverage, vaccination of boys may contribute to controlling infection, but because vaccination directly protects women from cervical cancer, more gains may be derived per additional girl vaccinated than per boy vaccinated. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

STD Facts - Human papillomavirus (HPV)


  http://www.cdc.gov/STD/HPV/STDFact-HPV.htm
HPV is so common that most sexually-active men and women will get at least one type of HPV at some point in their lives.Health problems related to HPV include genital warts and cervical cancer.Genital warts: About 360,000 people in the United States get genital warts each year.Cervical cancer: More than 11,000 women in the United States get cervical cancer each year.There are other conditions and cancers caused by HPV that occur in persons living in the United States.I'm pregnant. HPV can be passed even when an infected person has no signs or symptoms.Anyone who is sexually active can get HPV, even if you have had sex with only one person

CDC - Surveillance of Human Papillomavirus HPV - Chapter 5 - Vaccine Preventable Diseases


  http://www.cdc.gov/vaccines/pubs/surv-manual/chpt05-hpv.html
Although these outcomes are not nationally notifiable, a variety of activities have been established to monitor these endpoints in the US48 as described below. Data from the registries have been used to assess the pre-vaccine burden of HPV-associated cancers and will be the basis for monitoring relevant cancers post-vaccine introduction

  http://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet
In addition, the federal Vaccines for Children Program provides immunization services for children 18 and under who are Medicaid eligible, uninsured, underinsured, receiving immunizations through a Federally Qualified Health Center or Rural Health Clinic, or are Native American or Alaska Native. Gardasil 9 is as effective as Gardasil for the prevention of diseases caused by the four shared HPV types (6, 11, 16, and 18), based on similar antibody responses in participants in clinical studies

No comments:

Post a Comment